BOQALYCO

Serial Number 97899038
606

Registration Progress

Application Filed
Apr 20, 2023
Under Examination
Apr 16, 2024
Approved for Publication
Feb 2, 2024
Published for Opposition
Feb 20, 2024
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: BOQALYCO
Previous Owner: Pfizer Inc.
Classes: 005

Trademark Image

BOQALYCO

Basic Information

Serial Number
97899038
Filing Date
April 20, 2023
Published for Opposition
February 20, 2024
Abandonment Date
October 14, 2025
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Oct 14, 2025
Classes
005

Rights Holder

Pfizer Inc.

03
Address
66 Hudson Boulevard East
New York, NY 100012192

Ownership History

Pfizer Inc.

Original Applicant
03
New York, NY

Pfizer Inc.

Owner at Publication
03
New York, NY

Legal Representation

Attorney
Richard A. Friedman

USPTO Deadlines

All Deadlines Cleared

All 1 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

15 events
Date Code Type Description Documents
Oct 14, 2025 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Oct 14, 2025 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Sep 20, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 20, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
Sep 20, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
Sep 20, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 16, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 4, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 20, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 2, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 31, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 17, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 17, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 28, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 24, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use

Classification

International Classes
005